Drug Type Fusion protein |
Synonyms anti-transferrin receptor/anti-IDUA VNAR bispecific antibodies (Ossianix) |
Target |
Mechanism IDUA inhibitors(Alpha-L-iduronidase inhibitors), TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucopolysaccharidosis I | Discovery | US | - |